For the first time, a therapy has been found that can delay progression of metastatic uveal melanoma, a rare and deadly form of melanoma of the eye.

NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center. He assumed his new role on January 1, 2014.

“NY Med,” the hit television series filmed at NewYork-Presbyterian Hospital, returns to television this week. The second season of the series will premiere tomorrow, Thursday, June 26, at 10:00 p.m. Eastern time on ABC and will run for eight weeks.

Karen Westervelt Named Senior Vice President and Chief Operating Officer of the NewYork-Presbyterian Healthcare System

NewYork-Presbyterian Hospital is participating in a national multicenter trial to evaluate the Sentinel Cerebral Protection System (Sentinel), a medical device designed to prevent stroke in patients undergoing transcatheter aortic valve replacement (TAVR). The trial will assess Sentinel’s ability to capture embolic debris—calcified plaque built up in the arteries that can cause brain lesions or stroke—in the bloodstream.

Dr. Cam Patterson has been appointed senior vice president and chief operating officer at NewYork-Presbyterian/Weill Cornell Medical Center, effective January 6, 2014. Dr. Patterson arrives from the University of North Carolina, where he served in multiple leadership roles including physician-in-chief at the UNC Center for Heart and Vascular Care, executive director of the UNC McAllister Heart Institute, chief of the division of cardiology, and associate dean of health care entrepreneurship.

This past weekend, NewYork-Presbyterian Hospital brought together software designers and developers from around the city and country for InnovateNYP, New York's first hospital-focused hackathon. Seventeen teams worked around the clock to develop an innovation that would enhance and improve myNYP, the hospital's online patient portal, which allows patients to track their health records, coordinate doctors' appointments, and more.

NewYork-Presbyterian/Weill Cornell Medical Center has appointed two new division directors at its Phyllis and David Komansky Center for Children's Health. Dr. Eduardo Perelstein has been named director of the division of pediatric nephrology, and Dr. Christopher Cunniff has been named the new director of medical genetics. Both also hold faculty appointments at Weill Cornell Medical College.